FDA rejects Repligen’s imaging agent, shares drop 
June 22nd, 2012
Fri Jun 22, 2012 10:02am EDT (Reuters) – Repligen Corp said U.S. health regulators denied approval for its imaging agent to detect structural abnormalities in the pancreas, sending its shares down 10 percent. The U.S
[Continue Reading...]
GenVec’s cattle vaccine gets conditional approval, shares up 
June 7th, 2012
Thu Jun 7, 2012 11:28am EDT (Reuters) – GenVec Inc said its foot and mouth disease (FMD) vaccine got a conditional approval from a U.S.
[Continue Reading...]